Cargando…
Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines
Acute myeloid leukemia (AML) is characterized by a dysregulated expansion of poorly differentiated myeloid cells. Although patients are usually treated effectively by chemotherapy, a high rate of relapsed or refractory disease poses a major hurdle in its treatment. Recently, several studies have pro...
Autores principales: | Blöchl, Constantin, Wang, Di, Madunić, Katarina, Lageveen-Kammeijer, Guinevere S. M., Huber, Christian G., Wuhrer, Manfred, Zhang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616353/ https://www.ncbi.nlm.nih.gov/pubmed/34831278 http://dx.doi.org/10.3390/cells10113058 |
Ejemplares similares
-
Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
por: Blöchl, Constantin, et al.
Publicado: (2023) -
In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines
por: Wang, Di, et al.
Publicado: (2023) -
Glycosphingolipid-Glycan
Signatures of Acute Myeloid
Leukemia Cell Lines Reflect Hematopoietic Differentiation
por: Wang, Di, et al.
Publicado: (2022) -
Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype
por: Madunić, Katarina, et al.
Publicado: (2020) -
High sensitivity glycomics in biomedicine
por: Lageveen‐Kammeijer, Guinevere S. M., et al.
Publicado: (2021)